Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 27 Jul 2026 – 20 Aug 2026, limited by AlphaGrep Multi Asset Allocation Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | AlphaGrep Multi Asset Allocation Fund | Nifty 50 |
|---|---|---|
| 27 Jul 2026 | ₹100.00 | ₹100.00 |
| 29 Jul 2026 | ₹99.95 | ₹101.06 |
| 31 Jul 2026 | ₹100.30 | ₹101.62 |
| 02 Aug 2026 | ₹100.30 | ₹101.62 |
| 04 Aug 2026 | ₹100.77 | ₹102.58 |
| 06 Aug 2026 | ₹101.07 | ₹102.67 |
| 08 Aug 2026 | ₹101.19 | ₹102.39 |
| 10 Aug 2026 | ₹101.56 | ₹102.45 |
| 12 Aug 2026 | ₹102.32 | ₹101.83 |
| 14 Aug 2026 | ₹101.98 | ₹101.54 |
| 16 Aug 2026 | ₹101.98 | ₹101.54 |
| 18 Aug 2026 | ₹102.27 | ₹100.66 |
| 20 Aug 2026 | ₹103.03 | ₹100.98 |
| Metric | AlphaGrep · Regular NAV ₹10.31 High risk Unrated | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| — | +13.66% | |
| — | +15.55% | |
| — | +13.48% | |
| — | +11.02% | |
| +3.03% | +12.56% | |
| +450.01% | — | |
| — | +14.34% | |
| — | +11.77% | |
| — | +10.03% | |
| Risk | ||
| — | 10.32% | |
| — | 0.81 | |
| — | 1.11 | |
| -0.33% | -12.33% | |
| Nifty 50 | — | |
| — | +7.29% | |
| — | 0.62 | |
| — | 83.8% | |
| — | 24.4% | |
| 3.36% | 2.15% | |
| ₹52.98Cr | ₹2,048Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| — | 53% | |
| Ravneet Singh | — | |
| 27 Jul 2026 | — | |
| — | — | |
| — | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.